Genes & Cancer

Volume 14, 2023

Volume 14, 2023 is now on PubMed »

Volume 14 (2023)

About the Cover

The cover for Genes & Cancer Volume 13, 2022 features Figure 3 from "Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines" by Hannani et al.

Editorials

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

https://doi.org/10.18632/genesandcancer.228

Tatsuro Jo

p 1-2

PDF |  Press Release

Research Perspective

Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines

https://doi.org/10.18632/genesandcancer.229

Dalil Hannani, Estelle Leplus, Karine Laulagnier, Laurence Chaperot, and Joël Plumas

p 3-11

Abstract |  PDF |  Full Text |  Press Release

Reviews

CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

https://doi.org/10.18632/genesandcancer.230

Jerin Thomas, Addison Klebanov, Sahara John, Larry S. Miller, Anil Vegesna, Richard L. Amdur, Krishanu Bhowmick, and Lopa Mishra

p 12-29

Abstract |  PDF |  Full Text |  Press Release

Research Papers

VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer

https://doi.org/10.18632/genesandcancer.231

Ye S. Lee, Jennifer E. Klomp, Clint A. Stalnecker, Craig M. Goodwin, Yanzhe Gao, Gaith N. Droby, Cyrus Vaziri, Kirsten L. Bryant, Channing J. Der, and Adrienne D. Cox

p 30-49

Abstract |  PDF |  Full Text |  Supplementary Materials |  Supplementary Table 1 |  Press Release

Research Papers

A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature

https://doi.org/10.18632/genesandcancer.232

Kmira Zahra, Wided Cherif, Gereisha Ahmed, Haifa Regaieg, Ben Sayed Nesrine, Monia Zaier, Wided Mootamri, Yosra Ben Youssef, Nejia Brahem, Halima Sennana, and Abderrahim Khelif

p 50-55

Abstract |  PDF |  Full Text |  Press Release

Research Papers

Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma

https://doi.org/10.18632/genesandcancer.233

Drumond-Bock Ana Luiza, Wang Luyao, Wang Lin, Cybula Magdalena, Rostworowska Maria, Kinter Michael, and Bieniasz Magdalena

p 56-76

Abstract |  PDF |  Full Text |  Supplementary Materials |  Press Release